Oncology Imaging

Medical imaging has become integral to cancer care, assessing the stage and location of cancerous tumors. By utilizing powerful imaging modalities including CT, MRI, MRA and PET/CT, oncology imaging radiologists are able to assist referring physicians in the detection and diagnosis of cancer.

partnership business deal joint venture

Telix and Siemens Healthineers partner to advance oncologic therapies

Leaders from both companies are optimistic about how their partnership can improve precision medicine and palliative therapies. 

Thumbnail

AI spots more pancreatic cancer than radiologists

The use of artificial intelligence has the potential to significantly improve the diagnosis of pancreatic cancer, new data suggest. 

Telix Pharmaceuticals

Telix says new kidney cancer imaging agent alters treatment plans for 50% of patients

The positive findings come after the U.S. Food and Drug Administration previously shared concerns related to sterility assurance issues during the drug’s production.

Routine IR procedure could treat endometriosis.

ASTRO releases new radiation therapy guidelines for gastric cancers

Many forms of the disease are identified at later stages, making treatment and management complex and multifaceted. 

Thumbnail

Some PET exams may be overutilized in oncology

 In 2020 alone, there were more than 2 million 18F-FDG PET/CT scans conducted in the United States.

lung cancer pulmonary nodule

AI bests radiologists at predicting lung cancer treatment responses

More accurate response assessments could give providers an opportunity to proactively manage treatment decisions in the future.

Thumbnail

1st patient dosed with new radiopharmaceutical targeting cancer bone pain

The treatment can offer patients a more potent, cost-effective alternative providing long-lasting relief compared to current pain regimens.

Novartis seeks to expand use of prostate therapy Pluvicto, citing positive trial results

An expanded approval could potentially double the number of patients eligible for treatment with the therapy, first approved in 2022.